Silo Pharma, Inc. Balance Sheet
SILO|5 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Silo Pharma, Inc. had $7M in total assets and $6M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3.9M | $3.9M | $3.5M | $336.7K | $336.7K |
| Inventory | - | - | - | $156.4K | $156.4K |
| Current Assets | $7.1M | $7.1M | $7.7M | $493.8K | $493.8K |
| Total Assets | $7.4M | $7.4M | $7.7M | $493.8K | $493.8K |
| Current Liabilities | $1.7M | $1.7M | $775.6K | $116.7K | $116.7K |
| Shareholders' Equity | $6.2M | $6.2M | $10.3M | $407.4K | $407.4K |